Louisiana State Employees Retirement System Nektar Therapeutics Transaction History

Louisiana State Employees Retirement System

$5.06 Billion
Q1 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 19, 2023	SELL	$0.64 - $3.15 $1,088 - $5,355	-1,700 Reduced 1.9%	87,600 $61,000
Q4 2022 Jan 24, 2023	SELL	$2.03 - $4.28 $405 - $856	-200 Reduced 0.22%	89,300 $202,000
Q3 2022 Oct 19, 2022	SELL	$3.04 - $5.14 $1,824 - $3,084	-600 Reduced 0.67%	89,500 $286,000
Q2 2022 Jul 20, 2022	BUY	$3.17 - $6.17 $1,268 - $2,468	400 Added 0.45%	90,100 $339,000
Q1 2022 Apr 22, 2022	BUY	$4.16 - $13.72 $1,664 - $5,488	400 Added 0.45%	89,700 $418,000

Q4 2021 Jan 14, 2022	BUY	$10.83 - $18.41 $459,192 - $780,584	42,400 Added 90.41%	89,300 $1.21 Million
Q3 2021 Oct 12, 2021	SELL	$13.07 - $18.84 $5,228 - $7,536	-400 Reduced 0.85%	46,900 $842,000
Q1 2021 Apr 14, 2021	BUY	$16.56 - $25.46 $41,400 - $63,650	2,500 Added 5.58%	47,300 $946,000
Q4 2020 Jan 11, 2021	BUY	$15.77 - $19.03 $1,577 - $1,903	100 Added 0.22%	44,800 $762,000
Q3 2020 Oct 19, 2020	BUY	$16.59 - $24.79 $4,977 - $7,437	300 Added 0.68%	44,700 $742,000
Q2 2020 Jul 13, 2020	BUY	$16.86 - $23.44 $30,348 - $42,192	1,800 Added 4.23%	44,400 $1.03 Million
Q4 2019 Jan 17, 2020	BUY	$15.87 - $23.12 $676,062 - $984,912	42,600 New	42,600 $920,000
Q3 2019 Oct 24, 2019	SELL	$16.91 - $36.27 $147,117 - $315,549	-8,700 Closed	0 $0
Q2 2019 Jul 15, 2019	SELL	$31.0 - $36.3 $15,500 - $18,150	-500 Reduced 5.43%	8,700 $293,000
Q1 2019 Apr 15, 2019	BUY	$31.58 - $46.35 $3,158 - $4,635	100 Added 1.1%	9,200 $309,000
Q4 2018 Jan 14, 2019	SELL	$30.43 - $56.65 $30,430 - $56,650	-1,000 Reduced 9.9%	9,100 $299,000
Q3 2018 Oct 16, 2018	BUY	$46.46 - $68.49 $27,876 - $41,094	600 Added 6.32%	10,100 $616,000
Q2 2018 Jul 18, 2018	SELL	$46.25 - $104.45 $13,875 - $31,335	-300 Reduced 3.06%	9,500 $464,000
Q1 2018 Apr 18, 2018	SELL	$57.4 - $108.44 $3.32 Million - $6.28 Million	-57,900 Reduced 85.52%	9,800 $1.04 Million
Q4 2017 Jan 16, 2018	BUY	$23.02 - $60.5 $101,288 - $266,200	4,400 Added 6.95%	67,700 $4.04 Million
Q3 2017 Oct 16, 2017	BUY	$17.79 - $24.0 $1.13 Million - $1.52 Million	63,300	63,300 $1.52 Million

Others Institutions Holding NKTR

# of Institutions

128

Shares Held

111M

Call Options Held

150K

Put Options Held

Deep Track Capital, LP Greenwich, CT

18.4M
Shares

$21.5 Million
0.57% of portfolio
Vanguard Group Inc Valley Forge, PA

12M
Shares

$14.1 Million
0.0% of portfolio
Acadian Asset Management LLC Boston, MA

7.57M
Shares

$8.86 Million
0.02% of portfolio
Primecap Management CO Pasadena, CA

6.97M
Shares

$8.15 Million
0.0% of portfolio
Black Rock Inc. New York, NY

5.88M
Shares

$6.88 Million
0.0% of portfolio

View Full List

About NEKTAR THERAPEUTICS

Ticker NKTR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 187,404,992
Market Cap $219M
Description
Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in areas of unmet medical need in the United States and internationally. The company's products include Bempegaldesleukin, a CD122-preferential interleukin-2 (IL-2) pathway agonist, which is in phase 3 clinical trial to treat metastatic melanoma, re...

More about NKTR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Louisiana State Employees Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on Louisiana State Employees Retirement System with notifications on news.

Account